RED Option

AtheroGenics AGIX (news, chart, quote) - AGIX September options active at higher prices into Data

AGIX closed up .41 to $2.49. AGIX focuses on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases. AGIX announced on 8/29/07 new scientific data of its oral antidiabetic agent AGI-1067 will be presented at the European Society of Cardiology Congress on 9/5/07 in Vienna Austria. AGIX call option volume of 18,320 contracts compares to put volume of 13,171 contracts. AGIX at the money September 2.5 straddle is priced at .90 cents according to Track Data, suggesting larger price moment.

DISCLAIMER:
RED Option, in an attempt to provide the best resources from some of the industry's most capable people, has introduced our Market Minute commentary. RED Option does not endorse this commentary or information as trade recommendations nor does it have any input whatsoever into the decision making. Any content for the Market Minute is the sole opinion of the author.

Options involve risk and are not suitable for all investors. See the characteristics and risks of standardized options.

Email Us | Site Map | Terms & Conditions | Privacy Policy | Disclaimer